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Objective: This report presents the results of a prospective randomized study that compared 2 grafts of different diameter:
6 mm, and 8 mm tapered to 6 mm at the arterial site, placed in the upper arm for hemodialysis in a selected population
of patients younger than 71 years without diabetes.
Methods: Seventy consecutive patients younger than 71 years without diabetes who required an upper arm graft between
January 1997 and January 2002 and without previous access in the same limb were randomly allocated to receive either
a 6-mm graft or 6- to 8-mm graft. Graft flow was measured every 3 months with the Doppler dilution technique. When
access flow was less than 600 mL/min, fistulography was performed, and any stenosis was surgically treated with venous
outflow replacement. Thrombectomy and associated stenosis treatment in the same stage was performed in all cases
immediately after detection of thrombosis. Complication rate, and primary, assisted primary, and secondary patency rates
were compared between the two groups with the Student t test and life table analysis.
Results: Mean access flow was 975 mL/min for 6-mm grafts (range, 600-1500 mL/min; 95% confidence interval [CI],
889-1070), and for 6- to 8-mm grafts was 1397 mL/min (range, 1122-2700 mL/min; 95% CI, 1122-1672). This
difference was significant (P < .01). Complication rate was 0.45 episodes per graft-year in 6-mm grafts, and 0.19 episodes
per graft-year in 6- to 8-mm grafts (P < .01). At 1, 2, and 3 years, primary patency rates were 62%, 58%, and 44%,
respectively, for 6-mm grafts, and 85%, 78%, and 73% for 6- to 8-mm grafts; log-rank comparison between curves was P
 .0259. At 1, 2, and 3 years, secondary patency rates were 85%, 85%, and 85%, respectively, for 6-mm grafts, and 90%,
90%, and 90% for 6- to 8-mm grafts; log-rank comparison between curves was not significant, at P  .0603. At 1, 2, and
3 years, assisted primary patency rates were 84%, 79%, and 76%, respectively, for 6-mm grafts, and 90% for 6- to 8-mm
grafts; log-rank comparison was P  .0414
Conclusions: The results of this study show an advantage in terms of primary and assisted primary patency rates, and
complication rate for upper arm grafts with diameter 6 mm to 8 mm over grafts with 6-mm diameter in a patient
population younger than 70 years without diabetes. The finding of a similar secondary patency rate in both groups is
probably due to the surveillance program with sequential measurement of access flow and prompt surgical treatment of
stenosis. However, we needed twice the number of rescue procedures in 6-mm grafts to achieve a similar patency rate as
with large-bore grafts. These study results must be carefully evaluated, taking into consideration the small number of
patients and the selected patient population. (J Vasc Surg 2004;40:319-24.)Dr Kenneth C. Appell, a surgeon at Bronx Hospital in
New York, designed the radial-cephalic fistula as a vascular
access for hemodialysis, and the preliminary results were
published in 1966.1,2 Since then, autogenous radial-ce-
phalic direct wrist access has been the standard for vascular
access for dialysis. The many variants of autogenous elbow
fistulas, joining the brachial artery with one of the elbow
veins, can be used as a second choice for arteriovenous
access.3-7 A prosthetic access is indicated only when super-
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The usual diameter of prosthetic access grafts is 6 mm, at
least in Europe and the United States. In 1981 Humphries
et al8 advised use of brachial-axillary access grafts 8 mm in
diameter tapered to either 4 or 6 mm at the arterial site. The
upper arm is the preferred anatomic location for a pros-
thetic access at our center, because when a superficial vein is
available at the elbow an autogenous access is usually
performed at this site.9 In 1995 we presented a preliminary
report of 147 prosthetic brachial-axillary accesses 8 mm in
diameter tapered to 6 mm at the arterial site. The 2-year
primary patency rate was 60, and the 3-year secondary
patency rate was 80%. A further retrospective study that
analyzed 184 grafts 6 mm in diameter for prosthetic bra-
chial-axillary access and 324 prostheses 6 to 8 mm in the
same position has recently been published by our group.
The 5-year primary patency rate was 19% for 6-mm grafts,
and 39% for 6- to 8-mm grafts, and 5-year secondary
patency rate was 56% and 73%, respectively.10 However,
the favorable outcome with the large-bore grafts could
have resulted from bias in patient selection. The purpose of319
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ized study that compared prosthetic brachial-axillary ac-
cesses of 2 different diameters, that is, 6 mm, and 8 mm
tapered to 6 mm at the arterial site, in a selected population
of patients younger than 71 years without diabetes, with
axillary veins greater than 6 mm in diameter. Autogenous
access could not be performed in all of these patients,
because of absence of adequate superficial veins in the
forearm or the upper arm.
MATERIAL AND METHODS
Patient selection. Only patients younger than 71
years without diabetes were included in the study. The
reason for this patient selection was the observation in our
previous report of 6 times as many cases of clinical steal
syndrome when a 6- to 8-mm prosthetic brachial-axillary
access was performed in this patient population.10 Thus all
patients younger than 71 years without diabetes who re-
quired a prosthetic brachial-axillary access between January
1997 and January 2002 were randomly allocated to receive
either a 6-mm or 6- to 8-mm graft. Patients were excluded
if they had a previous access in the same limb or had an
axillary vein less than 6 mm in diameter. Seventy closed
envelopes were stored in the operating room. The envelope
containing the information on graft size was not opened
until the artery and vein were dissected, the vein was
opened, and a 6-mm arterial probe was easily passed into
the venous lumen. Arterial diameter was not taken into
consideration, but patients with 2 arteries in the elbow,
high bifurcation of the brachial artery, or aberrant superfi-
cial brachial artery were excluded from the study, and a
6-mm graft was used. All patients provided a preoperative
informed consent form, according to Spanish legal regula-
tions. No patient selected for randomization refused to
participate in the study. In the same period, the following
accesses were performed in our center in addition to the 70
prosthetic brachial-axillary accesses included in this study:
14 autogenous posterior radial branch–cephalic direct ac-
cesses, 239 autogenous radial-cephalic direct wrist accesses,
27 autogenous brachial-basilic side-to-side direct accesses,
52 autogenous brachial-cephalic upper arm indirect ac-
cesses, 13 autogenous brachial-cephalic upper arm direct
accesses, 14 prosthetic radial–median cubital forearm
straight accesses, 4 prosthetic brachial–antecubital forearm
loop accesses, 85 prosthetic brachial-axillary accesses, and
24 tunneled right jugular catheters.
Surgical technique. All patients were operated on
under local anesthesia with 0.25% alkalinized bupivacaine,
in an ambulatory setting unless the patient was hospitalized
for other reasons.11 Local anesthesia was administered into
the dermis at the axillary and elbow incision, under every
fascia before its opening, in the perivascular sheath, in the
subcutaneous tunnel, and again into the dermis before skin
closure. One hundred milliliters of anesthetic solution
(equivalent to 250 mg of bupivacaine) were usually used.
There were no adverse reactions to the local anesthetic.
Two grams of cephazolin were intravenously administered
before the start of the operation. Vancomycin (500 mgintravenously) was administered in patients allergic to lac-
tamic agents.
After artery and vein dissections, a 7-mm curved tun-
neled catheter (Gore-Tunneler; W. L. Gore & Associates)
was introduced close to the dermis, and maintained for a
few minutes while the skin over the device was compressed
with the fingers in an attempt to control any bleeding and
to make the graft as superficial as possible. The graft was
placed into the tunnel as soon as possible, to avoid graft
exposure. The graft reached the vein from the distal part of
the skin incision, to approach the vein at an acute angle.
The venous end of the graft was cut at an oblique angle.
The length of the vein incision was about 15 mm for the 2
graft sizes. Venous anastomosis was performed first, to the
posterior wall from inside. A vascular clamp was placed at
the graft close to the vein, which enabled the venous flow to
pass through the anastomotic site, to check the suture and
coagulate the graft holes under low-pressure venous flow.
Then the artery-graft anastomosis was performed, the graft
reaching the artery at a straight angle, and before the suture
was tied the graft clamp at the venous site was released. The
graft was filled with venous blood, the arterial suture was
tied, and the arterial clamps were removed. Blood did not
flow into the graft for a few seconds; thus heparin was not
needed. Polytetrafluoroethylene (PTFE) suture (CV8,
TT9; W. L. Gore & Associates), more or less equivalent to
7/0 conventional suture, was used for all anastomoses.
PTFE grafts were Gore-Tex stretch grafts (W. L. Gore &
Associates) 6 and 8 mm in diameter. In 8-mm grafts a
triangular portion, 6 mm in circumference and 20 mm
long, was removed at the arterial site, and the graft defect
was sutured with the same sutures as before.10
Surveillance protocol and treatment of failing
grafts. Graft flow was measured every 3 months with the
Doppler dilution technique (Transonic Instruments).
These studies were performed blindly by nurses in the
dialysis units. If access flow was less than 600 mL/min,
fistulography was performed, and any stenosis was surgi-
cally treated with a venous outflow PTFE replacement
graft.12 At fistulography, all patients with access flow less
than 600 mL/min had stenosis greater than 50% of the
graft diameter. Access flow, measured with the Transonic
instrument at the next dialysis after venous outflow replace-
ment, was greater than 800 mL/min.
Thrombectomy was performed in all cases immediately
after detection of thrombosis, and an effort was made to
detect and treat any associated stenosis at the same time.
The patients then underwent dialysis, and were discharged
to home. A completion fistulogram was always obtained.
Venous outflow replacement was performed together with
clot removal in 20 of 24 patients with thrombectomy in
6-mm grafts. Systematic curettage of the mid-access was
also performed during every case of thrombectomy when-
ever a 5-mm probe could not be easily passed through the
graft. Venous outflow replacement was performed together
with thrombectomy in 5 of 11 thrombosed 6- to 8-mm
grafts. Fistulography performed in patients after simple
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graft diameter.
Grafts with late periprosthetic infection at the puncture
sites were treated with partial graft removal and graft bypass
far from the infected site. In case of reinfection of the
prosthetic bypass, the graft was removed. Grafts were aban-
doned after repeated episodes of thrombosis without ste-
nosis. Grafts occluded in functioning renal transplants were
not repaired.
All grafts were used for dialysis when the analysis was
performed. Time from graft placement to first dialysis
ranged from 2 weeks (patients with non-tunneled femoral
catheters) to 4 months, and was not significantly different
in the 2 groups. No patient was lost to follow-up.
Statistical analysis. RSIGMA BABEL, a Spanish sta-
tistical software, was used for analysis. Quantitative vari-
ables were compared with the 2-sided t test; qualitative
variables were compared with the 2 test. Primary patency
was defined as the interval from the time of access place-
ment to any intervention designed to maintain or reestab-
lish patency, access thrombosis, or measurement of pa-
tency. Assisted primary patency was the interval from the
time of access placement until access thrombosis or mea-
surement of patency. Secondary patency was the interval
from the time of access placement to access abandonment
or to patency measurement. Patients who died with the
graft patent were considered excluded from the study at the
moment of death. Cumulative patency was calculated with
the life curve method. The log-rank test was used for curve
comparison.
RESULTS
Seventy patients were included in the study, 35 in the
6-mm graft group and 35 in the 6- to 8-mm graft group.
Mean age for the 6-mm group was 53.4 years (95% confi-
dence interval [CI], 49-58 years), and for the 6- to 8-mm
group was 50 years (95% CI, 45-54; P  .3033). Female
gender was 57% in both groups. In the 6-mm group, 17% of
patients were smokers compared with 22% in the 6- to
8-mm group (P  .2240). The percentage of patients
undergoing dialysis with a femoral non-tunneled catheter
was similar between groups: 14% in the 6-mm grafts group
and 17% in the 6- to 8-mm grafts group (P .7207). There
were no differences in the causes of renal failure between
the 2 groups. In patients needing temporary dialysis while
waiting for graft maturation, only non-tunneled femoral
catheters were used; subclavian or jugular catheters were
never used. Time between placement of a femoral tempo-
rary catheter and graft placement was always less than 5
days, because these patients are considered at delayed sur-
gical emergency in our center, and were never placed on a
waiting list.
No clinical steal syndrome requiring surgical or radio-
logic repair was observed in the 2 groups. Five patients in
the 6-mm group and 7 patients in the 6- to 8-mm group
had pallor or coolness of the hand, but these symptoms
resolved spontaneously in a few weeks.Mean access flow was 975 mL/min for 6-mm grafts
(range, 600-1500 mL/min; 95% CI, 889-1070 mL/min),
and was 1397 mL/min for 6- to 8-mm grafts (range,
1122-2700 mL/min; 95% CI, 1122-1672 mL/min). This
difference was significant (P  .0065) The patient with the
highest flow never developed alterations in cardiac func-
tion, and no change in ventricular mass or ejection fraction
was observed on echocardiograms. Flow was progressively
reduced to 1800 mL/min, probably as a result of intimal
hyperplasia, and therefore reduction flow surgery was not
considered. Complications are shown in the Table.
The complication rate was 0.45 episodes per graft-year
with 6-mm grafts and 0.19 episodes per graft-year with 6-
to 8-mm grafts (P  .0016). The most common complica-
tion was thrombosis, followed by graft-vein stenosis. Twice
the number of rescue procedures were needed in 6-mm
grafts compared with large-bore grafts. The number of
rescue procedures per patient in the 6-mm graft group was
1 procedure in 1 patient, 2 procedures in 2 patients, 3
procedures in 2 patients, 4 procedures in 4 patients, and 6
procedures in 6 patients, and in the 6- to 8-mm group was
1 procedure in 5 patients, 2 procedures in 2 patients, 3
procedures in 2 patients, and 5 procedures in 1 patient.
Primary patency rates were 62%, 58%, and 44%, respec-
tively, at 1, 2, and 3 years in the 6-mm graft group, and
85%, 78%, and 73%, respectively, in the 6- to 8-mm graft
group (P  .0259, log-rank test; Fig 1; Table II, online
only). Assisted primary patency rates at 1, 2, and 3 years
were 84%, 79%, and 76% in the 6-mm group, and 90% in
the 6- to 8-mm group (P  .0414, log-rank test; Fig 2;
Table III, online only). Secondary patency rates at 1, 2, and
3 years were 85%, 85%, and 85%, respectively, in the 6-mm
group, and 90%, 90%, and 90% in the 6- to 8-mm group
(P  .0603, log-rank test; Fig 3; Table IV, online only).
Seven patients died with a functioning graft, 4 in the 6-mm
group and 3 in the 6- to 8-mm group. In these patients
patency was measured from construction of the graft to the
moment of death.
DISCUSSION
The best diameter for prosthetic dialysis access is yet to
be defined. Most grafts used for dialysis are 6 mm in
diameter, at least in Europe and the United States. A
commercially available graft 7 mm in diameter tapered to 4
Episodes of complications needing surgical treatment
observed with both sizes of grafts
Complication
Graft size
6 mm 6-8 mm
Thrombosis 24 11
Stenosis 10 4
Infection at puncture site 6 3
Pseudoaneurysm 0 2
Total 40 20
Complication rate, grafts per year* .45 .19
*P  .0016.
JOURNAL OF VASCULAR SURGERY
August 2004322 Polo et almm at the arterial site was developed some years ago, but
no significant differences were found when compared with
6- mm grafts.13 The 2-year primary patency rate with 6-mm
PTFE grafts was between 25% and 34% in some recent
prospective randomized studies,13-16 far from our results
with 6- to 8-mm grafts in the upper arm, with 60% primary
patency rate at 2 years.10 However, our previous study was
retrospective, and some bias could have been introduced
with patient selection. On the other hand, all of our grafts
were placed in the upper arm, compared with prosthetic
brachial-antecubital forearm loop accesses in the aforemen-
tioned prospective studies of 6-mm grafts. The 2-year
primary patency rate in the present study was 78% for 6- to
8-mm grafts, but one reason could be selection of patients
younger than 71 years without diabetes. The most impor-
tant finding in the present prospective study is that the
primary patency rate for 6- to 8-mm brachial-axillary grafts
Fig 1. Life table curves for primary patency rates in 6
P  .0259, log-rank test. Standard error at 1, 2, and 3 y
.05 for 6- to 8-mm grafts.
Fig 2. Life table curves for assisted primary patency rates
P  .0414, log-rank test. Standard error at 1, 2, and 3 y
.05 for 6- to 8-mm grafts.was clearly superior to that for 6-mm grafts, and the com-
plication rate was less than twice. The assisted primary
patency rate was also superior with 6- to 8-mm prosthetic
brachial-axillary accesses.
There is no scientific basis for choosing 6-mm dialysis
grafts. It has been clearly shown that graft patency is
flow-dependent. The risk for thrombosis is high, with flow
less than 500 mL/min.17 Access flow can be measured with
echo Doppler color studies17 or Doppler dilution tech-
niques.18 Both techniques have been found similar in de-
tecting access stenosis,19 and they can be used, as well as
other commercially available on-line techniques, for sur-
veillance programs to treat stenosis before thrombotic ep-
isodes develop. According to Poiseuille’s law, flow in a tube
is mainly altered with small variations in tube diameter. In
theory, reduction in diameter due to intimal hyperplasia
development at the graft-vein junction will take longer to
and 6- to 8-mm prosthetic brachial-axillary accesses.
as .05, .06, and .07 for 6-mm grafts, and .02, .05, and
mm and 6- to 8-mm prosthetic brachial-axillary accesses.
as .05, .06, and .07 for 6-mm grafts; and .02, .05, and-mm
ears win 6-
ears w
JOURNAL OF VASCULAR SURGERY
Volume 40, Number 2 Polo et al 323decrease the flow to critical levels with the use of larger
grafts, because stenosis affects not only the vein but mostly
the last millimeters of length of the graft. On the other
hand, more than 20% of observed stenoses are mid-graft,
occurring at the puncture site,20 and these stenoses can
affect access flow in large-bore grafts less critically. We
observed a significant difference in access flow between the
two graft sizes, in favor of the larger bore grafts. This
finding supports the assumption that high flow can prolong
the life of dialysis grafts.
The second criterion for patient inclusion was age. We
believed, also without scientific support, that high flow
could be a drawback to cardiac function in older patients.
The purpose of the study was not to compare our results
with those obtained in other studies on grafts, but to
compare 2 different sizes of grafts. The reason for the
patient selection was to avoid the pernicious effects of
clinical steal syndrome or cardiac failure from use of a
large-bore graft in a patient population at high risk for these
complications.
The third criterion for selection was exclusion of pa-
tients with veins smaller than 6 mm in diameter. Most of
these cases were due to a proximal junction of upper arm
veins to form the axillary vein. But this selection lacks
scientific basis. It is true that turbulence occasioned by
extreme mismatching in the size of the graft and the vein
could induce intimal hyperplasia from the sheer effect over
the veins. However, we do not know whether a small deep
vein can enlarge under arterial flow, as usually happens with
superficial wrist fistulas. The selection of patients with
axillary veins larger than 6 mm could explain the good
results obtained in the 2 groups.
The results of this study clearly show a definite advan-
tage in terms of primary patency and complication rate in
upper arm grafts of 6- to 8-mm over 6-mm grafts in a
population of patients younger than 70 years of age with-
out diabetes.
The finding of similar secondary patency rates in both
groups is probably due to the surveillance program carried
Fig 3. Life table curves for secondary patency rates in 6-
.0603, log-rank test. Standard error at 1, 2, and 3 years w
6- to 8-mm grafts.out with sequential measurement of access flow and
prompt treatment of stenosis with surgical venous outflow
replacement. However, we needed twice the number of
rescue procedures in the 6-mm graft group to achieve
similar patency as with large-bore grafts.
We showed in another retrospective study that second-
ary patency can be the same with both autogenous and
prosthetic accesses when all complications are properly
treated. However, 6 times more rescue procedures were
needed with grafts compared with autogenous accesses to
achieve this similar secondary patency rate.21
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